{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:59:12Z","timestamp":1760241552010,"version":"build-2065373602"},"reference-count":55,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T00:00:00Z","timestamp":1525651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and objective: Optic neuritis (ON) is characterized by painful, usually monocular vision loss with decreased visual acuity and defects of the visual field and color vision. The etiology and pathophysiology of ON is not completely clear. It is thought that a matrix metalloproteinase 2 (MMP-2) gene plays an essential role in this autoimmune inflammatory disease. The aim of this study was to determine the relationship between the MMP-2 (-1306 C\/T) rs243865 gene polymorphism and ON, and that of ON with multiple sclerosis. Materials and methods: Patients with ON\/ON and multiple sclerosis and a control group of healthy individuals were enrolled in this study. The genotyping test of the MMP-2 (-1306 C\/T) was carried out using a real-time polymerase chain reaction (PCR) method. Results: Analysis revealed that T allele at the MMP-2 (-1306 C\/T) was less frequent in the ON group compared to the control group (14.5% vs. 23.3%, p = 0.031), and was associated with decreased likelihood of ON development (OR = 0.566; 95% CI: 0.333-0.962; p = 0.036). No significant associations were revealed while comparing the subgroups of ON patients with and without multiple sclerosis. Conclusion: The MMP-2 (-1306 C\/T) gene polymorphism was found to be associated with ON development.<\/jats:p>","DOI":"10.3390\/medicina54020029","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T02:48:08Z","timestamp":1525747688000},"page":"29","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of MMP-2 (\u20131306 C\/T) Gene Polymorphism with Predisposition to Optic Neuritis and Optic Neuritis Together with Multiple Sclerosis"],"prefix":"10.3390","volume":"54","author":[{"given":"Rasa","family":"Liutkevi\u010dien\u0117","sequence":"first","affiliation":[{"name":"Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Kaunas LT-50161, Lithuania"},{"name":"Department of Ophthalmology, Medical Academy, Lithuanian University of Health Sciences, Kaunas LT-50161, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0427-5568","authenticated-orcid":false,"given":"Alvita","family":"Vilkevi\u010di\u016bt\u0117","sequence":"additional","affiliation":[{"name":"Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Kaunas LT-50161, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mantas","family":"Banevi\u010dus","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Medical Academy, Lithuanian University of Health Sciences, Kaunas LT-50161, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raminta","family":"Mie\u017eyt\u0117","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, Kaunas LT-44307, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loresa","family":"Kriau\u010di\u016bnien\u0117","sequence":"additional","affiliation":[{"name":"Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Kaunas LT-50161, Lithuania"},{"name":"Department of Ophthalmology, Medical Academy, Lithuanian University of Health Sciences, Kaunas LT-50161, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,5,7]]},"reference":[{"key":"ref_1","first-page":"182","article-title":"Optic neuritis","volume":"5","author":"Dooley","year":"2010","journal-title":"J. Ophthalmic Vis. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/archneur.57.7.974","article-title":"Multiple sclerosis from probable to definite diagnosis: A 7-year prospective study","volume":"57","author":"Achiron","year":"2000","journal-title":"Arch. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11556-010-0062-9","article-title":"Exercise, and the potential for older adults","volume":"7","author":"Horton","year":"2010","journal-title":"Eur. Rev. Aging Phys. Act."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1756285611398702","article-title":"Clinical approach to optic neuritis: Pitfalls, red flags and differential diagnosis","volume":"4","author":"Voss","year":"2011","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kaushik, M., Wang, C.Y., Barnett, M.H., Garrick, R., Parratt, J., Graham, S.L., Sriram, P., Yiannikas, C., and Klistorner, A. (2013). Inner nuclear layer thickening is inversley proportional to retinal ganglion cell loss in optic neuritis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0078341"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/oxfordjournals.bmb.a071390","article-title":"Pathophysiology of demyelinating disease","volume":"33","author":"Halliday","year":"1977","journal-title":"Br. Med. Bull."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1874364101206010065","article-title":"Optic Neuritis, its Differential Diagnosis and Management","volume":"6","author":"Hoorbakht","year":"2012","journal-title":"Open Ophthalmol. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jnnp-2013-305907","article-title":"Autocrine MMP-2\/9 secretion increases the BBB permeability in neuromyelitis optica","volume":"85","author":"Tasaki","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2015.06.014","article-title":"MMP-2 -1575G\/A polymorphism modifies the onset of optic neuritis as a first presenting symptom in MS?","volume":"286","author":"Lavtar","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1759-1961.2010.009.x","article-title":"T cell migration into the central nervous system during health and disease: Different molecular keys allow access to different central nervous system compartments","volume":"1","author":"Engelhardt","year":"2010","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1699-0463.1999.tb01532.x","article-title":"Matrilysin in early stage intestinal tumorigenesis","volume":"107","author":"Fingleton","year":"1999","journal-title":"APMIS"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1006\/scbi.2000.0379","article-title":"Matrix metalloproteinases in tumor invasion and metastasis","volume":"10","author":"Stamenkovic","year":"2000","journal-title":"Semin. Cancer Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1026028303196","article-title":"Regulation of matrix metalloproteinases an overview","volume":"253","author":"Chakraborti","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"Nagase","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s000180050495","article-title":"Matrix metalloproteinases in tumor invasion","volume":"57","author":"Johansson","year":"2000","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C","article-title":"Matrix metalloproteinases in tumour invasion and metastasis","volume":"189","author":"Curran","year":"1999","journal-title":"J. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/07853899909019260","article-title":"Matrix metalloproteinases and their inhibitors in tumour growth and invasion","volume":"31","author":"Kahari","year":"1999","journal-title":"Ann. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1096\/fasebj.13.8.781","article-title":"Regulation of matrix metalloproteinase expression in tumor invasion","volume":"13","author":"Westermarck","year":"1999","journal-title":"FASEB J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0955-0674(00)00248-9","article-title":"Matrix metalloproteinases: They\u2019re not just for matrix anymore!","volume":"13","author":"McCaswley","year":"2001","journal-title":"Curr. Opin. Cell. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1167\/iovs.13-13630","article-title":"MMPs in the neuroretina and optic nerve: Modulators of glaucoma pathogenesis and repair?","volume":"55","author":"Dekeyster","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jneuroim.2011.04.009","article-title":"Increased serum matrix metalloproteinase-9 in neuromyelitis optica: Implication of disruption of blood\u2013brain barrier","volume":"236","author":"Hosokawa","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0945-053X(00)00102-5","article-title":"Polymorphism in matrix metalloproteinase gene promoters: Implication in regulation of gene expression and susceptibility of various diseases","volume":"19","author":"Ye","year":"2000","journal-title":"Matrix Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.1074\/jbc.M010242200","article-title":"Identification of novel, functional genetic variants in the human matrix metalloproteinases-2 gene: Role of SP1 in allele-specific transcriptional regulation","volume":"276","author":"Price","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000063355","article-title":"Genotype association of C(-735)T polymorphism in matrix metalloproteinase 2 gene with G(8002)A endothelin 1 gene with plaque psoriasis","volume":"204","author":"Vasku","year":"2002","journal-title":"Dermatology"},{"key":"ref_26","first-page":"82","article-title":"Optic neuritis: A review","volume":"16","author":"Shams","year":"2009","journal-title":"Int. MS J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00002018-200831020-00003","article-title":"Drug-induced ocular disorders","volume":"31","author":"Li","year":"2008","journal-title":"Drug Saf."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/jnnp.2005.073247","article-title":"Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes","volume":"77","author":"Swanton","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1474-4422(07)70176-X","article-title":"MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: A multicentre retrospective study","volume":"6","author":"Swanton","year":"2007","journal-title":"Lancet Neurol."},{"key":"ref_31","first-page":"30334","article-title":"The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes","volume":"21","author":"Hannocks","year":"2017","journal-title":"Matrix Biol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Optic Neuritis Study Group (1991). The clinical profile of optic neuritis. Experience of the optic neuritis treatment trial. Arch. Ophthalmol., 109, 1673\u20131688.","DOI":"10.1001\/archopht.1991.01080120057025"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/glia.10108","article-title":"Matrix metalloproteinases in neuroinflammation","volume":"39","author":"Rosenberg","year":"2002","journal-title":"Glia"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune T cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"364ra152","DOI":"10.1126\/scitranslmed.aaf8020","article-title":"Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier","volume":"8","author":"Gerwien","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nbd.2006.02.006","article-title":"Blood\u2013brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation","volume":"23","author":"Gurney","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-8993(95)01089-0","article-title":"Tumor necrosis factor-\u03b1-induced gelatinase B causes delayed opening of the blood-brain barrier: An expanded therapeutic window","volume":"703","author":"Rosenberg","year":"1995","journal-title":"Brain Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0006-8993(92)90681-X","article-title":"TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase","volume":"576","author":"Rosenberg","year":"1992","journal-title":"Brain Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(96)00179-8","article-title":"Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: An overview","volume":"72","author":"Chandler","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ana.1218","article-title":"Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients","volume":"50","author":"Galboiz","year":"2001","journal-title":"Ann. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2990.1997.tb01315.x","article-title":"Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke","volume":"23","author":"Anthony","year":"1997","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/brain\/awg285","article-title":"Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis","volume":"126","author":"Nuttall","year":"2003","journal-title":"Brain"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/jnr.22257","article-title":"Divergent role for MMP-2 in myelin breakdown and oligodendrocyte death following transient global ischemia","volume":"88","author":"Walker","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00005072-199603000-00005","article-title":"Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions","volume":"55","author":"Maeda","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2990.2006.00766.x","article-title":"Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions","volume":"32","author":"Vos","year":"2006","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/jim-2016-000111","article-title":"Analysis of MMP2-1306C\/T and TIMP2G-418C polymorphisms with relapsing remitting multiple sclerosis","volume":"64","author":"Aksoy","year":"2016","journal-title":"J. Investig. Med."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Modvig, S., Degn, M., and Horwitz, H. (2013). Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0077163"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF02282984","article-title":"The clinical and paraclinical profile of optic neuritis: A prospective study","volume":"16","author":"Soderstrom","year":"1995","journal-title":"Ital. J. Neurol. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1167\/iovs.14-15408","article-title":"The role of B cells in the early onset of the first demyelinating event of acute optic neuritis","volume":"56","author":"Feldman","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0198-8859(93)90184-3","article-title":"The influence of HLA-DR and -DQ alleles on progression to multiple sclerosis following a clinically isolated syndrome","volume":"37","author":"Kelly","year":"1993","journal-title":"Hum. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1212\/WNL.49.5.1413","article-title":"Risk factors for developing multiple sclerosis after childhood optic neuritis","volume":"49","author":"Lucchinetti","year":"1997","journal-title":"Neurology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/archneur.1997.00550130058016","article-title":"HLA typing in acute optic neuritis","volume":"54","author":"Frederiksen","year":"1997","journal-title":"Arch. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/jnnp.50.6.758","article-title":"A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up","volume":"50","author":"Francis","year":"1987","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.4049\/jimmunol.181.8.5473","article-title":"Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis","volume":"181","author":"Caillier","year":"2008","journal-title":"J. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0002-9394(14)70994-8","article-title":"The association of HLA-DR15 and intermediate uveitis","volume":"123","author":"Tang","year":"1997","journal-title":"Am. J. Ophthalmol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/54\/2\/29\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:03:39Z","timestamp":1760195019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/54\/2\/29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,7]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,5]]}},"alternative-id":["medicina54020029"],"URL":"https:\/\/doi.org\/10.3390\/medicina54020029","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2018,5,7]]}}}